Evolocumab
Last Updated: 02/24/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1229 publications
Effect of evolocumab on the gut microbiota in patients with acute myocardial infarction.
Journal: Journal of medical microbiology
Published: January 13, 2026
Expanded indication for PCSK9 inhibitors.
Journal: The Medical letter on drugs and therapeutics
Published: December 15, 2025
Highlights of Cardiovascular Disease Prevention Studies Presented at the 2025 American Heart Association Scientific Sessions.
Journal: Current atherosclerosis reports
Published: December 02, 2025
VESALIUS Keeps Revolutionizing Medicine: The Case of Evolocumab in Primary Prevention.
Journal: European heart journal. Cardiovascular pharmacotherapy
Published: November 14, 2025
Protective Effects of PCSK9 Inhibitors on Renal Function in ASCVD Patients at High Risk for Contrast-Associated Acute Kidney Injury.
Journal: Angiology
Published: November 13, 2025
Evolocumab in Patients without a Previous Myocardial Infarction or Stroke.
Journal: The New England journal of medicine
Published: November 10, 2025
Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors: A Novel Therapy in the Treatment of Cholesterol Crystal Embolism-Induced Kidney Injury.
Journal: Kidney medicine
Published: November 10, 2025
Efficacy and Safety of Very Low Achieved LDL-Cholesterol in Patients with Prior Ischemic Stroke.
Journal: Circulation
Published: November 03, 2025
Efficacy and Safety of Very Low Achieved LDL Cholesterol in Patients With Previous Ischemic Stroke.
Journal: Circulation
Published: November 03, 2025
Evolocumab-Induced Angioedema: First Documented Case and Review of a Rare Adverse Event.
Journal: JACC. Case reports
Published: October 29, 2025
Last Updated: 02/24/2026